| NCT Number | NCT07589010 |
| Lead Sponsor | Muhammad Aamir Latif |
| Conditions | Peripheral Intravenous Line |
| Enrollment | 192 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-03-31 (estimated) |
| Study Completion | 2026-03-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-15 |